Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.
复制标题
DOI:
10.1002/hep.26672
复制
发表时间:
2014-02
期刊:
影响因子:
13.5
通讯作者:
Shulman, Gerald I.
中科院分区:
文献类型:
--
作者:
Birkenfeld, Andreas L.;Shulman, Gerald I.
Non alcoholic fatty liver disease (NAFLD), hepatic insulin resistance and type 2 diabetes are all strongly associated and are all reaching epidemic proportions. Whether there is a causal link between NAFLD and hepatic insulin resistance is controversial. This review will discuss recent studies in both humans and animal models of NAFLD that have implicated increases in hepatic diacylglycerol content leading to activation of PKCε resulting in decreased insulin signaling in the pathogenesis of NAFLD associated hepatic insulin resistance and type 2 diabetes. The DAG-PKCε hypothesis can explain the occurrence of hepatic insulin resistance observed in most cases of NAFLD associated with obesity, lipodystrophy and type 2 diabetes.
登录
查看更多内容
影响因子:
29
作者:
Erion DM;Ignatova ID;Yonemitsu S;Nagai Y;Chatterjee P;Weismann D;Hsiao JJ;Zhang D;Iwasaki T;Stark R;Flannery C;Kahn M;Carmean CM;Yu XX;Murray SF;Bhanot S;Monia BP;Cline GW;Samuel VT;Shulman GI
通讯作者:
Shulman GI
DOI:
10.1074/jbc.m111.228817
发表时间:
2011-10-21
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Birkenfeld AL;Lee HY;Majumdar S;Jurczak MJ;Camporez JP;Jornayvaz FR;Frederick DW;Guigni B;Kahn M;Zhang D;Weismann D;Arafat AM;Pfeiffer AF;Lieske S;Oyadomari S;Ron D;Samuel VT;Shulman GI
通讯作者:
Shulman GI
影响因子:
2.9
作者:
Gholam, PM;Kotler, DP;Flancbaum, LJ
通讯作者:
Flancbaum, LJ
DOI:
10.1073/pnas.1311176110
发表时间:
2013-07-30
影响因子:
11.1
作者:
Galbo, Thomas;Perry, Rachel J.;Shulman, Gerald I.
通讯作者:
Shulman, Gerald I.
DOI:
10.1073/pnas.1212887109
发表时间:
2012-09-11
影响因子:
11.1
作者:
Brown, Whitney H.;Gillum, Matthew P.;Shulman, Gerald I.
通讯作者:
Shulman, Gerald I.